SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Rani Therapeutics Holdings, Inc.
@RANI_InsiderForm 4 Filing: Imran Talat Sells $55,028.15 of $RANI
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Rani Therapeutics Holdings, Inc.
Ticker: $RANI
Transaction Value
$55,028.15
Price/Share: $0.92
transaction date
2024-12-27
Shares: 60,015
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Imran Talat, holds the title of Chief Executive Officer at Rani Therapeutics Holdings, Inc..
On 2024-12-27, the insider transacted 60,015 shares.The shares were transacted at a weighted average price of $0.92 per share, resulting in a total market-relevant value of $55,028.15.
Executive Summary Summary
Imran Talat (Chief Executive Officer) sold $55K of $RANI
Post-Transaction Position: 486,737 shares
SEC Accession No: 0001869579-26-000006 (CIK: 1869579)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.